Augmentation of NRF2 signaling by SFN treatment is hence anticipated to rescue cancer cells from oxidative DNA damage, which in turn promotes tumor growth and survival in DEN-induced hepatocarcinogenesis. The gene discussed is NFE2L2; the disease is neoplasm.